We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Guide for marketing authorisation holders, including qualified person responsible for pharmacovigilance (PV) and pharmacovigilance system master files (PSMF).
Information for healthcare professionals on how pulse oximeters are regulated, home use and issues to look out for when using the devices
Take care when using creams to treat dry skin conditions as they can easily dry onto clothing, bedding and bandages, making them more flammable.
What you need to do before your product can be placed on the Great Britain market with a UKCA mark.
How to comply with the requirements on promoting medicines to the public and to prescribers and suppliers of medicines
The Medicines and Healthcare Regulatory Agency have launched RegulatoryConnect, a service that provides the capability to track applications and view live authorisation details.
This guidance clarifies the expectations on the application of the EU guidance on good pharmacovigilance practices (GVP)
Guidance for Applicants wishing to apply for a Promising Innovative Medicines designation, pre-submission meeting or an EAMS Scientific Opinion.
How the MHRA makes decisions on whether a borderline product is a medical device and which risk class should apply.
This guidance summarises our approach to pharmacovigilance
Guidance on transitional arrangements for the Clinical Trials Regulations.
How the MHRA processes variations to medicines' marketing authorisations for the UK and Northern Ireland.
Information on how ICH E6(R3) good clinical practice (GCP) principles are implemented and enforced in UK clinical trial legislation.
Patient factsheet providing information on respiratory syncytial virus (RSV) and RSV vaccination.
Patient factsheet providing information on influenza (flu) and flu vaccination.
Safety leaflet to help you understand the latest information about the effects of pregabalin during pregnancy.
A wholesale dealer in Great Britain may import Qualified Person certified medicines from the European Economic Area if certain checks are made by the ‘Responsible Person (import)’
Comply with good pharmacovigilance practice and prepare for an inspection.
How to get a marketing authorisation (MA) for an advanced therapy medicinal product (ATMP) so it can be sold and/or supplied in the United Kingdom.
Information about the MHRA graduate scheme which is currently closed for applications.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).